API prices fall sharply, easing pressure on India's pharmaceutical industry

India's pharmaceutical industry is experiencing relief as active pharmaceutical ingredient (API) prices plummet due to overcapacity and aggressive pricing strategies from Chinese suppliers. Increased domestic API production, driven by government incentives and reduced raw material costs, further contribute to the decline. This trend is expected to continue, boosting profit margins for Indian pharma companies.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Opcv5mG
via IFTTT

0 comments:

Post a Comment